SXI Life Sciences
|
7 772,36
|
-3,32
|
-0,04 %
|
Analysen zu SXI Life Sciences-Werten
| 16.05.24 | Roche Underweight | JP Morgan Chase & Co. | |
| 16.05.24 | Roche Hold | Jefferies & Company Inc. | |
| 14.05.24 | Roche Neutral | UBS AG | |
| 06.05.24 | Roche Neutral | UBS AG | |
| 06.05.24 | Novartis Buy | UBS AG |